Six-Year Survival after Orthotopic Liver Transplantation (OLTtx) Using De Novo Combination Treatment of Mtor Inhibitor Everolimus (ERL) with Mycophanolate Sodium (MPS): 2281 von Antoniou, E. A., Paraskeva, P., Mantas, D., Smyrnis, A., Labathariou, K., Karoussos, D., Dimitroulis, D., Kykalos, S., Voutsarakis, A., Kandylis, A., Tsinari, K.

Volltext

DE NOVO USE OF MTOR INHIBITOR EVEROLIMUS IN COMBINATION WITH MYCOPHANOLATE SODIUM IN PATIENTS UNDERGONE ORTHOTOPIC LIVER TRANSPLANTATION: 1251 von Antoniou, E, Dimitroulis, D, Mantas, D, Flessas, M, Labathariou, K, Nikitakis, N, Paraskeva, P, Karoussos, D, Tsinari, K, Kostatkis, A

Volltext